课题基金 / 基金详情

Generation of Wolfram syndrome mice, aiming at development of new therapeutics for diabetes through preserving pancreatic beta cells

Generation of Wolfram syndrome mice, aiming at development of new therapeutics for diabetes through preserving pancreatic beta cells
培育 Wolfram 综合征小鼠,旨在通过保存胰腺 β 细胞开发糖尿病新疗法
批准号:
12357007
负责人:
OKA Yoshitomo
金额:
$26.05万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2002

项目摘要

项目成果

OKA Yoshitomo的其他基金

相似基金

相关文献

中文摘要
翻译
Wolfram综合征是一种常染色体隐性遗传疾病,与青少年发病的糖尿病、视神经萎缩、感音神经性耳聋和尿崩症有关。我们确定,采用定位克隆,一个基因负责这种疾病,并指定它WFS 1。我们还发现WFS 1蛋白定位于ER膜。此外,WFS 1与酵母Hrd 3 p有一些序列相似性,后者参与错误折叠蛋白质的ER相关降解。因此,虽然WFS 1蛋白似乎在ER应激反应中发挥作用,但其确切功能仍有待澄清。为了阐明这种新蛋白的功能和Wolfram综合征的病理生理学,我们产生了缺乏WFS 1基因的小鼠(WFS 1-KO)。雄性WFS 1-KO小鼠的血糖水平在约12周时开始升高,并且在24周时显著高于野生型小鼠的血糖水平(267±33 vs 146±34 mg/dl)。这与胰岛β细胞的损失有关; WFS 1-KO小鼠的全胰腺胰岛素含量比野生型小鼠低30倍(11±4 vs 287±34 ng/mg胰腺)。使用抗WFS 1蛋白抗体的胰腺免疫组织化学分析显示,WFS 1蛋白在外分泌组织中不存在,但在内分泌β细胞中强烈表达。WFS 1蛋白在胰高血糖素阳性细胞中不表达,大多数生长抑素和胰多肽阳性细胞缺乏WFS 1免疫反应性。在WFS 1-KO小鼠中,β细胞数量随着年龄的增长而下降,而α细胞略有增加,并分散在整个胰岛中。这些结果强烈表明,WFS 1蛋白在β细胞的存活和/或再生中起关键作用,并且胰岛β细胞的进行性丧失是这种疾病中糖尿病的主要原因。
英文摘要
Wolfram syndrome is an autosomal recessive disorder associated with juvenile onset diabetes mellitus, optic atrophy, sensorineural deafness and diabetes insipidus. We identified, employing positional cloning, a gene responsible for this disorder and designated it WFS1. We also showed WFS1 protein to be localized in the ER membrane. In addition, WFS1 shares some sequence similarity with yeast Hrd3p, which is involved in ER-associated degradation of malfolded proteins. Thus, though WFS1 protein appears to play a role in the ER-stress response, its precise function remains to be clarified. To elucidate the functions of this novel protein and the pathophysiology of Wolfram syndrome, we have generated mice lacking the WFS1 gene (WFS1-KO). WFS1-KO mice are normal in appearance, growth and fertility Blood glucose levels in male WFS1-KO mice start to rise at around 12 weeks and are significantly higher than those of wild-type mice at 24 weeks (267±33 vs 146±34 mg/dl). This is associated with loss of islet β cells; whole pancreatic insulin content in WFS1-KO mice was 30-times lower than that in wild-type mice (11±4 vs 287±34 ng/mg pancreas). Immunohistochemical analysis of the pancreas using an anti-WFS1 protein antibody revealed that WFS1 protein is absent from exocrine tissue, but is strongly expressed in endocrine β cells. WFS1 protein is not expressed in glucagon-positive cells and the majority of somatostatin-, and pancreatic polypeptide-positive cells are devoid of WFS1 immunoreactivity. In WFS1-KO mice, β cell number fell with age, while a cells were somewhat increased and were scattered throughout the islet. These results strongly suggest WFS1 protein to play a critical role in survival and/or regeneration of β cells and progressive loss of islet β cells to be the major cause of diabetes in this disorder.
期刊论文(29)
专著(0)
科研奖励(0)
会议论文
Nakazaki M, Kakei M, Ishihara H, Koriyama N, Hashiguchi H, Aso K, Fukudome M, Oka Y, Yada T: "Association of upregulated activity of KATP channels with impaired insulin secretion in UCP1-expressing insulinoma cells"J Physiology. 540・3. 781-789 (2002)
Nakazaki M、Kakei M、Ishihara H、Koriyama N、Hashiguchi H、Aso K、Fukudome M、Oka Y、Yada T:“表达 UCP1 的胰岛素瘤细胞中 KATP 通道活性上调与胰岛素分泌受损的关联”J Physiology 540。・3.781-789(2002)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yujiri T et al: "MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinas regulation but does not cause a measurable defectin NFkB activation."PNAS. 97. 7272-7 (2000)
Yujiri T 等人:“MEK 激酶 1 基因破坏会改变细胞迁移和 c-Jun NH2 末端激酶调节,但不会导致 NFkB 激活出现可测量的缺陷。”PNAS。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Tanizawa Y, Nakai K, Sasaki T, Ohta Y, Inoue H, Matuo K, Koga M, Furukawa S, Oka Y: "Unregulated elevation of glutamate dehydrogenase activity induces glutamine-stimulated insulin secretion: Identification and characterization of a GLUD1 gene mutation, an
Tanizawa Y、Nakai K、Sasaki T、Ohta Y、Inoue H、Matu K、Koga M、Furukawa S、Oka Y:“谷氨酸脱氢酶活性不受调节的升高诱导谷氨酰胺刺激的胰岛素分泌:GLUD1 基因突变的鉴定和表征,
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Suzuki Y, et al.: "Lipoma and sensory neuropathy in mitochondrial diabetes associated with tRNA mutation at position 3271"Diabetes Care. 25. 407-408 (2002)
Suzuki Y 等人:“与 3271 位 tRNA 突变相关的线粒体糖尿病中的脂肪瘤和感觉神经病”糖尿病护理。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 22 条
    Pancreatic β cell impairment and adaptation of type 2 diabetes mellitus in overnutrition era
    • 批准号:
      19209034
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $31.78万
    • 财政年份:
      2007
    • 负责人:
      OKA Yoshitomo
    • 依托单位:
    Molecular mechanisms for pancreatic beta cell failure・a viewpoint from endoplasmic reticulum stress
    • 批准号:
      17390258
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.6万
    • 财政年份:
      2005
    • 负责人:
      OKA Yoshitomo
    • 依托单位:
    Studies on mechanisms of insulin-stimulated glucose transport : analysis of downstream signaling and real-time monitoring of GLUT4 translocation
    • 批准号:
      13470226
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.37万
    • 财政年份:
      2001
    • 负责人:
      OKA Yoshitomo
    • 依托单位:
    Elucidation of diabetes-related genes
    • 批准号:
      13204062
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $21.44万
    • 财政年份:
      2001
    • 负责人:
      OKA Yoshitomo
    • 依托单位:
    国内基金
    海外基金
    同源异形盒基因HvVvl介导20E信号通路和insulin信号通路调控茄二十八星瓢虫变态发育的分子机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      潘慧鹏
    • 依托单位:
    基于稳态吸收和DPP-IV/GLP-1/Insulin通路解析牡蛎肽协同花色苷的降血糖增效机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      陈忠琴
    • 依托单位:
    Dif/FoxO激活miRNA调节Toll与insulin信号交互促进果蝇免疫代谢平衡的机制研究
    • 批准号:
      32370516
    • 项目类别:
      面上项目
    • 资助金额:
      51万元
    • 批准年份:
      2023
    • 负责人:
      马飞
    • 依托单位:
    基于多组学解析光环境促Insulin基因甲基化抑制PI3K/ACTBL2延缓近视发展的分子机制
    • 批准号:
      82301246
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      黄煜
    • 依托单位: